Abstract
In order to investigate activation and internalization of c-kit we created a functional c-kit-EGFP chimera by inserting EYFP (enhanced yellow fluorescent protein) within the extracellular domain of c-kit immediately downstream of the signal sequence, SS-EYFP-kit. This location was chosen because the C-terminal fusion of EGFP to c-kit unexpectedly caused constitutive activation of the c-kit tyrosine kinase. As analysed in fixed cells and by real time imaging in vivo, SCF induced activation led to internalization of the fusion construct and translocation to punctate structures resembling vesicles. Analysis of the internalization process by time lapse imaging revealed high mobility and discontinuous movement of these vesicles and their predominantly radial tracks. Two subsets of vesicles were observed: Traffic of the majority of vesicles was directed from the periphery to the center of the cell and most likely represents the internalization of activated receptor molecules via the endosomal pathway. However, some vesicular structures were observed to move towards the periphery of the cell and probably contain newly synthesized protein to replace internalized receptor molecules. The calculated velocity of moving vesicles ranged from 0.05 to 0.2 μm per se. Vesicle formation upon SCF induced dimerization of the receptor was strictly dependent on kinase activity of c-kit. Treatment of cells with phenylarsine oxide, an agent blocking receptor internalization, prior to SCF stimulation resulted in abrogation of the translocation of the chimera to vesicles whereas accumulation of vesicles was observed when cells were treated with proteasome inhibitors. Cholesterol depletion of the cell membrane by methyl-β-cyclodextrin resulted in dose dependent reduction of receptor internalization indicating that c-kit may be present in lipid rafts or that intact lipid rafts are required for efficient internalization of the receptor. Using the induction of vesicular structures as a sign of efficient internalization of the receptor analysis of mutant c-kit constructs deficient either in activation of PI3-Kinase or Src revealed that internalization of c-kit is dependent on recruitment of Src but not PI3-Kinase.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Beaumont V, Hepworth MB, Luty JS, Kelly E, Henderson G . 1998 J. Biol. Chem. 273: 33174–33183
Beslu N, LaRose J, Casteran N, Birnbaum D, Lecocq E, Dubreuil P, Rottapel R . 1996 J. Biol. Chem. 271: 20075–20081
Blume-Jensen P, Jiang G, Hyman R, Lee KF, O'Gorman S, Hunter T . 2000 Nat. Genet. 24: 157–162
Broudy VC . 1997 Blood 90: 1345–1364
Broudy VC, Lin NL, Buhring HJ, Komatsu N, Kavanagh TJ . 1998 Blood 91: 898–906
Broudy VC, Lin NL, Liles WC, Corey SJ, O'Laughlin B, Mou S, Linnekin D . 1999 Blood 94: 1979–1986
Carter RE, Sorkin A . 1998 J. Biol. Chem. 273: 35000–35007
Caruana G, Cambareri AC, Ashman LK . 1999 Oncogene 18: 5573–5581
Clarkson BD, Strife A, Wisniewski D, Lambek C, Carpino N . 1997 Leukemia 11: 1404–1428
Coutinho S, Jahn T, Lewitzky M, Feller S, Hutzler P, Peschel C, Duyster J . 2000 Blood 96: 618–624
De Angelis DA, Miesenbock G, Zemelman BV, Rothman JE . 1998 Proc. Natl. Acad. Sci. USA 95: 12312–12316
Deberry C, Mou S, Linnekin D . 1997 Biochem. J. 327: 73–80
Duyster J, Baskaran R, Wang JY . 1995 Proc. Natl. Acad. Sci. USA 92: 1555–1559
Feng Y, Minnerly JC, Zurfluh LL, Joy WD, Hood WF, Abegg AL, Grabbe ES, Shieh JJ, Thurman TL, McKearn JP, McWherter CA . 1999 Biochemistry 38: 4553–4563
Fischer M, Goldschmidt J, Peschel C, Brakenhoff JP, Kallen KJ, Wollmer A, Grotzinger J, Rose-John S . 1997 Nat. Biotechnol. 15: 142–145
Gommerman JL, Rottapel R, Berger SA . 1997 J. Biol. Chem. 272: 30519–30525
Gordon GW, Berry G, Liang XH, Levine B, Herman B . 1998 Biophys J. 74: 2702–2713
Hallek M, Danhauser-Riedl S, Herbst R, Warmuth M, Winkler A, Kolb HJ, Druker B, Griffin JD, Emmerich B, Ullrich A . 1996 Br. J. Haematol. 94: 5–16
Joly M, Kazlauskas A, Corvera S . 1995 J. Biol. Chem. 270: 13225–13230
Kanakura Y, Furitsu T, Tsujimura T, Butterfield JH, Ashman LK, Ikeda H, Kitayama H, Kanayama Y, Matsuzawa Y, Kitamura Y . 1994 Leukemia 8: (Suppl 1) 18–S22
Keller P, Simons K . 1998 J. Cell. Biol. 140: 1357–1367
Krystal GW, DeBerry CS, Linnekin D, Litz J . 1998 Cancer Res. 58: 4660–4666
Kurzchalia TV, Parton RG . 1999 Curr. Opin. Cell. Biol. 11: 424–431
Langley KE, Bennett LG, Wypych J, Yancik SA, Liu XD, Westcott KR, Chang DG, Smith KA, Zsebo KM . 1993 Blood 81: 656–660
Lennartson J, Blume-Jensen P, Hermanson M, Ponten E, Carlberg M, Ronnstrand L . 1999 Oncogene 18: 5546–5553
Li Q, Kondoh G, Inafuku S, Nishimune Y, Hakura A . 1996 Cancer Res. 56: 4343–4346
Liu L, Cutler RL, Mui AL, Krystal G . 1994 J. Biol. Chem. 269: 16774–16779
Longley BJ, Tyrrell L, Ma Y, Williams DA, Halaban R, Langley K, Lu HS, Schechter NM . 1997 Proc. Natl. Acad. Sci. USA 94: 9017–9021
Mahajan NP, Linder K, Berry G, Gordon GW, Heim R, Herman B . 1998 Nat. Biotechnol. 16: 547–552
Miyazawa K, Toyama K, Gotoh A, Hendrie PC, Mantel C, Broxmeyer HE . 1994 Blood 83: 137–145
Moran M, Miceli MC . 1998 Immunity 9: 787–796
Oliferenko S, Paiha K, Harder T, Gerke V, Schwarzler C, Schwarz H, Beug H, Gunthert U, Huber LA . 1999 J. Cell. Biol. 146: 843–854
Serve H, Yee NS, Stella G, Sepp-Lorenzino L, Tan JC, Besmer P . 1995 EMBO J. 14: 473–483
Shimizu Y, Ashman LK, Du Z, Schwartz LB . 1996 J. Immunol. 156: 3443–3449
Simons K, Ikonen E . 1997 Nature 387: 569–572
Thommes K, Lennartsson J, Carlberg M, Ronnstrand L . 1999 Biochem. J. 341: 211–216
Timokhina I, Kissel H, Stella G, Besmer P . 1998 EMBO J. 17: 6250–6262
Wakioka T, Sasaki A, Mitsui K, Yokouchi M, Inoue A, Komiya S, Yoshimura A . 1999 Leukemia 13: 760–767
Wu H, Klingmuller U, Besmer P, Lodish HF . 1995 Nature 377: 242–246
Yee NS, Hsiau CW, Serve H, Vosseller K, Besmer P . 1994 J. Biol. Chem. 269: 31991–31998
Acknowledgements
This work was supported by a grant to J Duyster from the José-Carreras Stiftung and Mildren-Scheel Siftung and by SFB grant No 456 to J Duyster and C Peschel. T Jahn and C Miething are supported by a fellowship from the Deutsche José-Carreras Stiftung. We thank Kenneth I Weinberg, Children's Hospital Los Angeles, for very helpful suggestions and comments and critically reading the manuscript. We thank Dr Christian Heinemann, TILL Photonics, for friendly and skilful support. We thank Claudia Mugler for technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jahn, T., Seipel, P., Coutinho, S. et al. Analysing c-kit internalization using a functional c-kit-EGFP chimera containing the fluorochrome within the extracellular domain. Oncogene 21, 4508–4520 (2002). https://doi.org/10.1038/sj.onc.1205559
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205559
Keywords
This article is cited by
-
The unfolded protein response modulators GSK2606414 and KIRA6 are potent KIT inhibitors
Cell Death & Disease (2019)
-
Oncogenic Kit signals on endolysosomes and endoplasmic reticulum are essential for neoplastic mast cell proliferation
Nature Communications (2014)
-
Characteristics of Cardiac Cell Cultures Derived from Human Myocardial Explants
Bulletin of Experimental Biology and Medicine (2013)
-
Prognostic significance of c-KIT in vulvar cancer: bringing this molecular marker from bench to bedside
Journal of Translational Medicine (2012)
-
Kit
AfCS-Nature Molecule Pages (2011)